UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000014163
Receipt No. R000016482
Scientific Title Phase II study of Neoadjuvant Eribulin followed by FEC for operable triple-negative breast cancer
Date of disclosure of the study information 2014/07/01
Last modified on 2018/07/01 17:58:59

No. Disposal Last modified on Item of update
1 Insert 2014/06/04 19:28:31
2 Update 2014/06/05 12:48:10 Institutions
3 Update 2014/07/15 17:54:07 Recruitment status
Anticipated trial start date
4 Update 2014/07/16 17:22:02 UMIN ID1
5 Update 2014/07/24 11:55:59 Institutions
6 Update 2015/04/06 14:00:51 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Organization1
Institutions
7 Update 2015/11/16 09:14:49 Recruitment status
8 Update 2018/07/01 17:58:59 Recruitment status


Contact us.